title: Irrelevance of explicit cost-effectiveness thresholds when coverage decisions can be reversed.
authors.forename: Anirban
authors.initials: A
authors.lastname: Basu
mesh_terms: D020811:Biomedical Technology / Q000191:economics*; D002017:Budgets; D003362:Cost-Benefit Analysis; D003657:Decision Making; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D019057:Quality-Adjusted Life Years